MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-RJ-17-0053928
Mittal Pharma Private Limited
Mittal Pharma Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.38 Cr
▲ 40% YoY
Net profit · FY 2025
₹20.49 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹76.55 Lakh
EBITDA margin 2.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹5.01 Cr
Satisfied ₹2.83 Cr
Company age
30 yrs
Est. 1996
Directors on board
3
As per MCA filings
About Mittal Pharma Private Limited
Data last updated:
Mittal Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1996PTC013061. Its GSTIN is 08AABCM5389G1Z7 (Rajasthan).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Arpan Gupta and Ravindra Prasad Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. 101 – 102 Dawabazar Film Colony, Jaipur, Rajasthan, India – 302005.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.38 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹20.49 Lakh (net margin 0.7%) and EBITDA of ₹76.55 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹5.01 Cr and satisfied charges of ₹2.83 Cr on record.
Mittal Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0053928). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232RJ1996PTC013061
Registration Number 013061
Incorporation Date 31 December 1996
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-RJ-17-0053928
Recognitions & Rankings of Mittal Pharma
Contact details
Mittal Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 101 – 102 Dawabazar Film Colony, Jaipur, Rajasthan, India – 302005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mittal Pharma Private Limited, buy the company report.
Comprehensive company report
Mittal Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mittal Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mittal Pharma Private Limited, buy the company report.
Financials of Mittal Pharma Private Limited
FY 2024 filings availableMittal Pharma Private Limited reported revenue of ₹27.38 Cr (up 40% YoY) for FY 2025.
Revenue · FY 2025
₹27.38 Cr ▲ 40%
Net profit · FY 2025
₹20.49 Lakh margin 0.7%
EBITDA · FY 2025
₹76.55 Lakh margin 2.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 16%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 9%
5 years · compounded
▲ 8%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 40% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mittal Pharma Private Limited, buy the company report.
Board of directors of Mittal Pharma Private Limited
Mittal Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arpan Gupta | Director | 31 Mar 2001 | 25 Years 6 Months | Current |
| Ravindra Prasad Gupta | Director | 31 Dec 1996 | 29 Years 9 Months | Current |
| Jyoti Gupta | Director | 24 Mar 2004 | 22 Years 7 Months | Current |
Peer comparison
Mittal Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apollo Medi-Services Pvt. Ltd. | ₹27.89 Cr (FY 2024) | 32.0% | Kolkata, West Bengal, India | |||
| Bhalla Distributors Private Limited | ₹27.79 Cr (FY 2025) | 8.0% | Utter Pradesh, Uttar Pradesh, India | |||
| MKS Pharma Limited | ₹27.73 Cr (FY 2017) | -83.0% | New Delhi, Delhi, India | |||
| Prakas Pharmacy Private Limited | ₹27.6 Cr (FY 2024) | -6.0% | Chennai, Tamil Nadu, India | |||
| Mittal Pharma Private Limitedthis company | ₹27.38 Cr (FY 2025) | ₹20.49 Lakh | 0.7% | 40.0% | Jaipur, Rajasthan, India | |
| Sivam Remedies Private Limited | ₹27.3 Cr (FY 2025) | 27.0% | Chennai, Tamil Nadu, India | |||
| Nexus Lifecare Private Limited | ₹27.24 Cr (FY 2025) | -21.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mittal Pharma Private Limited, buy the company report.
Auditor
Mittal Pharma Private Limited is audited by S.C. BAPNA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.C. BAPNA & ASSOCIATES | FY 2023 | 115649W |
Shareholding
The shareholding of Mittal Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mittal Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.01 Cr
Satisfied charges
₹2.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jun 2020 | 100350138 | Others | ₹36 Lakh | Open | |
| 25 Apr 2019 | 100261184 | Others | ₹4.65 Cr | Open | |
| 05 Jul 2017 | 100110426 | Others | ₹68 Lakh | Satisfied | |
| 17 May 2008 | 10103849 | Fingrowth Co-Operative Bank Ltd | ₹1.2 Cr | Satisfied | |
| 01 Mar 2002 | 90073963 | Uco Bank | ₹90 Lakh | Satisfied |
To see the full charge records of Mittal Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Mittal Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mittal Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mittal Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AABCM5389G1Z7 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mittal Pharma Private Limited, buy the company report.
Recent activity
Mittal Pharma Private Limited has 3 board changes on record since 1996: 3 appointments. The latest: Jyoti Gupta was appointed as Director on 24 Mar 2004.
AGM
Mittal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Mittal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
Charges
A charge with Others of Rs. 36.00 Lakh registered on 26 Jun 2020 with Charge ID 100350138 was modified on 11 Jan 2022.
Charges
A charge with Others of Rs. 465.00 Lakh registered on 25 Apr 2019 with Charge ID 100261184 was modified on 17 Dec 2021.
Charges
A charge with Others amounted to Rs. 36.00 Lakh with Charge ID 100350138 was registered on 26 Jun 2020.
Charges
A charge registered on 05 Jul 2017 via Charge ID 100110426 with Others was fully satisfied on 18 Jun 2019.
Charges
A charge registered on 02 Feb 1999 via Charge ID 90072962 with Urban Co-Operative Bank Ltd. was fully satisfied on 18 Jun 2019.
Charges
A charge with Others amounted to Rs. 465.00 Lakh with Charge ID 100261184 was registered on 25 Apr 2019.
Charges
A charge registered on 17 May 2008 via Charge ID 10103849 with Fingrowth Co-Operative Bank Ltd was fully satisfied on 21 Nov 2017.
Charges
A charge with Others amounted to Rs. 68.00 Lakh with Charge ID 100110426 was registered on 05 Jul 2017.
Charges
A charge with Fingrowth Co-Operative Bank Ltd of Rs. 120.00 Lakh registered on 17 May 2008 with Charge ID 10103849 was modified on 04 Mar 2015.
Charges
A charge registered on 01 Mar 2002 via Charge ID 90073963 with Uco Bank was fully satisfied on 24 May 2008.
8 earlier events are in the company report.
Frequently asked questions
Mittal Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 December 1996 (30+ years old) and is registered under CIN U24232RJ1996PTC013061.
Mittal Pharma has 3 current directors:
- Arpan Gupta - Director
- Ravindra Prasad Gupta - Director
- Jyoti Gupta - Director
The latest financial statements of Mittal Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Mittal Pharma is 08AABCM5389G1Z7, registered in Rajasthan.
The CIN (Corporate Identification Number) of Mittal Pharma is U24232RJ1996PTC013061. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mittal Pharma was incorporated on 31 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Mittal Pharma by revenue are Apollo Medi-Services Pvt. Ltd, Bhalla Distributors Private Limited, MKS Pharma Limited, Prakas Pharmacy Private Limited, Sivam Remedies Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Jyoti Gupta was appointed as Director on 24 Mar 2004. Arpan Gupta was appointed as Director on 31 Mar 2001. Ravindra Prasad Gupta was appointed as Director on 31 Dec 1996.
Yes, Mittal Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-RJ-17-0053928).
The registered office of Mittal Pharma is at Shop No. 101 – 102 Dawabazar Film Colony, Jaipur, Rajasthan, India – 302005.
Mittal Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.